Acute myeloid leukaemia (in remission) Withdrawn Phase 2 Trials for Fludarabine (DB01073)

Also known as: Acute Myeloid Leukemia in Remission / Acute myeloid leukemia (in remission) / Acute myeloblastic leukemia, in remission / Acute myeloid leukaemia in remission

IndicationStatusPhase
DBCOND0006975 (Acute myeloid leukaemia (in remission))Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03399773Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Hematologic MalignanciesTreatment